Analyst Price Target is $4.75
▲ +665.64% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for P3 Health Partners in the last 3 months. The average price target is $4.75, with a high forecast of $5.00 and a low forecast of $4.50. The average price target represents a 665.64% upside from the last price of $0.62.
Current Consensus is
Moderate Buy
The current consensus among 3 investment analysts is to moderate buy stock in P3 Health Partners. This Moderate Buy consensus rating has held steady for over two years.